Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$463,875
+$52,563 QoQ
Shares Held
1,281
+9.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#2,240
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Enterprise Financial Services Corp holds $12,653,618 across 10 Drug Manufacturers - General names. AMGN ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,105 | $3,297,741 | |
| 2 | LLY |
ELI LILLY & Co
|
2,069 | $2,481,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,619 | $2,392,541 | |
| 4 | JNJ |
Johnson & Johnson
|
8,275 | $2,101,601 | |
| 5 | PFE |
Pfizer Inc
|
24,377 | $586,998 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,281 | $463,875 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,683 | $442,694 | |
| 8 | NVS |
Novartis AG
|
2,081 | $326,133 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $463,875 | 1,281 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $411,312 | 1,169 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $377,060 | 1,152 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $308,726 | 1,094 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $310,760 | 1,113 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $330,243 | 1,060 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $280,188 | 1,075 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $356,686 | 1,107 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $364,316 | 1,166 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $326,683 | 1,149 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $456,799 | 1,586 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $431,091 | 1,604 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $347,017 | 1,563 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $396,953 | 1,642 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $437,295 | 1,665 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $603,395 | 2,677 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $640,852 | 2,634 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $371,435 | 1,536 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $321,707 | 1,430 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $448,478 | 2,109 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $193,049 | 792 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $228,904 | 920 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $207,157 | 901 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $226,709 | 892 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $210,386 | 892 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $172,522 | 851 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||